XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of estimated useful lives of property, plant and equipment

Production equipment

    

3 to 13 years

Office furniture and equipment

 

3 to 10 years

Buildings

 

39 years

Building improvements

 

15 years

Schedule of significant customers

Three Months Ended

Three Months Ended

    

March 31, 2022

    

March 31, 2021

Number of significant customers

 

3

 

1

 

Aggregate dollar amount of net sales to significant customers

$

33.8

million

$

37.8

million

Percentage of net sales to significant customers

75.6%

75.5%

Schedule of disaggregated information of revenue recognized from contracts with customers and licensing fees

For the three months ended March 31, 2022:

    

    

Blood 

    

    

    

Total 

Collection 

EasyPoint®

Other 

Product

Geographic Segment

Syringes

Products

Needles

Products

 Sales

U.S. sales (excluding U.S. government)

$

8,395,303

$

1,077,695

$

729,970

$

9,874

$

10,212,842

Sales to U.S. government

15,731,136

15,731,136

North and South America sales (excluding U.S.)

 

11,074,246

 

 

2,608

 

274

 

11,077,128

Other international sales

 

7,505,438

 

211,368

 

2,888

 

1,550

 

7,721,244

Total

$

42,706,123

$

1,289,063

$

735,466

$

11,698

$

44,742,350

For the three months ended March 31, 2021:

    

    

Blood 

    

    

    

Total

Collection

EasyPoint®

Other 

Product 

Geographic Segment

Syringes

 Products

Needles

Products

Sales

U.S. sales (excluding U.S. government)

$

8,759,314

574,008

1,612,333

15,536

$

10,961,191

Sales to U.S. government

37,782,360

37,782,360

North and South America sales (excluding U.S.)

 

825,820

11,968

109,440

 

947,228

Other international sales

 

199,316

37,350

144780

1,500

 

382,946

Total

$

47,566,810

$

611,358

$

1,769,081

$

126,476

$

50,073,725

Schedule of diluted EPS under the treasury stock method

Three Months Ended

Three Months Ended

    

March 31, 2022

    

March 31, 2021

Common Stock underlying issued and outstanding stock options

96,244

 

152,967

Common stock issuable upon the conversion of convertible preferred shares

232,445

 

257,945

328,689

 

410,912

Schedule of earnings per share

Three Months Ended

Three Months Ended

    

March 31, 2022

    

March 31, 2021

Net income

$

7,616,455

$

17,955,884

Preferred stock dividend requirements

 

(58,111)

 

(64,938)

Income applicable to common shareholders

$

7,558,344

$

17,890,946

Average common shares outstanding

 

33,265,453

 

33,967,771

Average common and common equivalent shares outstanding — assuming dilution

 

33,594,142

 

34,378,683

Basic earnings per share

$

0.23

$

0.53

Diluted earnings per share

$

0.23

$

0.52